| Literature DB >> 28063894 |
Xiaojia Ren1, Daret K St Clair2, D Allan Butterfield3.
Abstract
One of the major complaints patients who survive cancer often make is chemotherapy induced cognitive impairment (CICI), which survivors often call "chemo brain." CICI is a side effect of chemotherapy due to the cytotoxicity and neurotoxicity of anti-cancer drugs causing structural and functional changes in brain, even when drugs that do not cross the blood brain barrier (BBB) are used. Diminished cognitive functions including diminution of learning and memory, concentration and attention, processing speed and executive functions that reduce quality of life and ability to work are common signs and symptoms of CICI. There still is not a clarified and complete mechanism for CICI, but researchers have pointed to several biochemical candidates. Chemotherapy-induced, cytokine-mediated involvement in CICI will be mainly discussed in this review paper with emphasis on different types of cytokines, correlated with BBB and epigenetic changes. Mechanisms of ROS-generating, anti-cancer drugs and their relation to cytokine-mediated CICI will be emphasized.Entities:
Keywords: Cancer chemotherapy; Chemobrain; Cognition dysfunction; Cytokines and epigenetics changes
Mesh：
Substances：
Year: 2017 PMID： 28063894 DOI： 10.1016/j.phrs.2017.01.001
Source DB: PubMed Journal: Pharmacol Res ISSN： 1043-6618 Impact factor: 7.658